GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,602,000 | -13.5% | 50,137 | -6.3% | 0.00% | 0.0% |
| Q1 2022 | $1,853,000 | +18.3% | 53,484 | -0.1% | 0.00% | +33.3% |
| Q4 2021 | $1,567,000 | +15.5% | 53,539 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,357,000 | -26.8% | 53,267 | +0.6% | 0.00% | -25.0% |
| Q2 2021 | $1,854,000 | -12.6% | 52,938 | +1.6% | 0.00% | -20.0% |
| Q1 2021 | $2,122,000 | -64.4% | 52,091 | -62.1% | 0.01% | -64.3% |
| Q4 2020 | $5,957,000 | +17.2% | 137,528 | +49.2% | 0.01% | 0.0% |
| Q3 2020 | $5,081,000 | +470.9% | 92,148 | +553.0% | 0.01% | +366.7% |
| Q2 2020 | $890,000 | +23.6% | 14,111 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $720,000 | -35.7% | 14,111 | -53.6% | 0.00% | -40.0% |
| Q1 2017 | $1,120,000 | +50.5% | 30,400 | -40.9% | 0.01% | +66.7% |
| Q4 2016 | $744,000 | -37.3% | 51,470 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $1,187,000 | +39.0% | 51,470 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $854,000 | – | 51,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |